Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune System Stimulation via Antigen Presentation by Autologous Dendritic Cells Pulsed with Tumor Antigens (DC Vaccine (Autologous, Tumor Antigen-Pulsed))
- Target
- DC Vaccine (Autologous, Tumor Antigen-Pulsed)
- Molecular classification
- Cell-based therapy, Immunotherapy, Antigen-presenting cell, Vaccine
01
Overview
Autologous dendritic cell vaccines pulsed ex vivo with patient-specific tumor antigens represent a promising form of personalized immunotherapy designed to harness potent adaptive immune responses against cancer by leveraging the natural biology of professional APC function. This approach has demonstrated safety, feasibility, strong immunogenicity—including TH1/TH17 polarization—and encouraging clinical outcomes across multiple solid tumors. Ongoing research seeks further optimization regarding manufacturing protocols and combination regimens.
- Other names
- Autologous dendritic cell vaccineTumor antigen-pulsed dendritic cell vaccineDC vaccinePersonalized cancer vaccine
02
Mechanism of action
Dendritic cells present tumor-associated antigens to T cells, leading to T cell activation and anti-tumor immune response.
03
Biological functions
Antigen presentationT cell activationImmune responseCytokine productionAnti-tumor immunity
04
Disease associations
CancerMetastatic MelanomaGlioblastoma
05
Safety considerations
Injection site reactionsPotential for autoimmunityCytokine release syndromeTumor lysis syndrome
06
Interacting drugs
GM-CSF
2 more in the full profile.
07
Biomarkers
Delayed-type hypersensitivity (DTH) response to autologous tumor cellsTH1/TH17 polarization markers (e.g., IFN-gamma, IL-17)Tumor regressionDisease-free survival
Beyond the preview
Go deeper on Immune System Stimulation via Antigen Presentation by Autologous Dendritic Cells Pulsed with Tumor Antigens (DC Vaccine (Autologous, Tumor Antigen-Pulsed)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immune System Stimulation via Antigen Presentation by Autologous Dendritic Cells Pulsed with Tumor Antigens (DC Vaccine (Autologous, Tumor Antigen-Pulsed)).